Table 3. Immune reconstitution of... | American Society of Hematology

Table 3.

Immune reconstitution of patients after haplo-HCT

	1 mo	3 mo	6 mo	12 mo	24 mo
TCRαβ⁺/CD19⁺-depleted HCT*
CD3⁺ T cells/µL	265 ± 110	366 ± 229	707 ± 179	832 ± 250	1640 ± 414
CD3⁺CD4⁺ T cells/µL	33 ± 17	58 ± 23	190 ± 38	295 ± 74	608 ± 106
CD3⁺CD8⁺ T cells/µL	175 ± 73	97 ± 17	272 ± 33	415 ± 140	868 ± 347
CD19⁺ B cells/µL	4 ± 2	287 ± 109	270 ± 91	307 ± 103	205 ± 60
CD3⁻CD56⁺ NK cells/µL	199 ± 49	174 ± 53	274 ± 76	182 ± 49	429 ± 141
CD34⁺*selected- and/or CD3⁺/CD19⁺-depleted HCT
CD3⁺ T cells/µL	140 ± 88	626 ± 252	736 ± 216	1014 ± 238	2390 ± 559
CD3⁺CD4⁺ T cells/µL	17 ± 11	78 ± 29	148 ± 43	423 ± 97	934 ± 203
CD3⁺CD8⁺ T cells/µL	120 ± 77	531 ± 218	528 ± 147	559 ± 147	1314 ± 311
CD19⁺ B cells/µL	9 ± 2	320 ± 94	151 ± 54	600 ± 241	539 ± 169
CD3⁻CD56⁺ NK cells/µL	255 ± 51	152 ± 39	127 ± 27	413 ± 151	481 ± 246

	1 mo	3 mo	6 mo	12 mo	24 mo
TCRαβ⁺/CD19⁺-depleted HCT*
CD3⁺ T cells/µL	265 ± 110	366 ± 229	707 ± 179	832 ± 250	1640 ± 414
CD3⁺CD4⁺ T cells/µL	33 ± 17	58 ± 23	190 ± 38	295 ± 74	608 ± 106
CD3⁺CD8⁺ T cells/µL	175 ± 73	97 ± 17	272 ± 33	415 ± 140	868 ± 347
CD19⁺ B cells/µL	4 ± 2	287 ± 109	270 ± 91	307 ± 103	205 ± 60
CD3⁻CD56⁺ NK cells/µL	199 ± 49	174 ± 53	274 ± 76	182 ± 49	429 ± 141
CD34⁺*selected- and/or CD3⁺/CD19⁺-depleted HCT
CD3⁺ T cells/µL	140 ± 88	626 ± 252	736 ± 216	1014 ± 238	2390 ± 559
CD3⁺CD4⁺ T cells/µL	17 ± 11	78 ± 29	148 ± 43	423 ± 97	934 ± 203
CD3⁺CD8⁺ T cells/µL	120 ± 77	531 ± 218	528 ± 147	559 ± 147	1314 ± 311
CD19⁺ B cells/µL	9 ± 2	320 ± 94	151 ± 54	600 ± 241	539 ± 169
CD3⁻CD56⁺ NK cells/µL	255 ± 51	152 ± 39	127 ± 27	413 ± 151	481 ± 246

Data are expressed as means ± standard error of the mean.

There was no statistically significant difference between the 2 groups with respect to each cell subset determined at different time points.